Insider · CIK 0001619612
Kathleen Sereda Glaub
Files at IOBT (IO Biotech, Inc.). First filing -, latest -.
In brief
Kathleen Sereda Glaub files SEC Form 4 as director at IOBT (IO Biotech, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kathleen Sereda Glaub has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 5, 2025 | IOBT IO Biotech, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +35,144 | $0.00 | $0 | 35,144 | Jun 6, 2025 |
Questions about Kathleen Sereda Glaub
Answered from the filings on this page, as of the latest one.
Is Kathleen Sereda Glaub buying or selling?
Kathleen Sereda Glaub has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kathleen Sereda Glaub's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kathleen Sereda Glaub has 0.
Where does Kathleen Sereda Glaub file Form 4?
Kathleen Sereda Glaub has filed Form 4 at IOBT (IO Biotech, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.